Method of use of antiarrhythmic 1-arylcarbamoylalkyl imidazole
申请人:Berlex Laboratories, Inc.
公开号:US04415587A1
公开(公告)日:1983-11-15
Novel 1,2-disubstituted imidazol(in)es are described herein. The compounds are generally produced by reacting a haloacylanilide with an excess of 2-substituted-imidazol(in)e. The compounds are antiarrhythmic agents.
Novel 1,2-disubstituted imidazol(in)es are described herein. The compounds are generally produced by reacting a haloacylanilide with an excess of 2-substituted-imidazol(in)e. The compounds are antiarrhythmic agents.